Randomized controlled trials in *Obesity* and *Diabetes Care* show that patients achieving 1015% weight loss over 1218 months maintain that loss long-term, while those losing weight rapidly often regain it
Monitoring your bodys response constantly and alerting professionals at the onset of serious symptoms will lead to safer and more effective results
Mechanisms of action: two distinct cascades BPC-157: NO pathway modulation and growth factor expression Preclinical studies have suggested that BPC-157 acts primarily through three axes: NO (nitric oxide) pathway : BPC-157 modulates endothelial NO signaling, favoring local vasodilation and perfusion of injured tissues VEGF-R2 expression and angiogenesis : animal models have shown increased formation of new capillaries at the injury site Interactions with dopaminergic, serotonergic and GABAergic pathways : BPC-157 exhibits a pleiotropic profile influencing neurological and digestive healing Documented strengths (animal models): healing of tendons, ligaments, gastrointestinal mucosa, bone, teeth, vessels, cornea
2020Glucagon-like peptide-1 receptor agonists and prevention of stroke systematic review of cardiovascular outcome trials with meta-analysis
On the other hand, phentermine is more affordable and generally well-tolerated but carries a risk of cardiovascular side effects and is not recommended for those unable to tolerate stimulants
